Philips Unveils Trilogy Evo and Growing Portfolio of Connected Solutions at ERS 2018

Amsterdam and Paris (ots/PRNewswire) -

New portable ventilator builds on Philips respiratory clinical
excellence to enhance transitional care coordination and
collaboration

At the European Respiratory Society (ERS) International Congress
2018 in Paris, France (September 15-19), Royal Philips
(http://www.usa.philips.com/) (NYSE: PHG) (AEX: PHIA), a global
leader in health technology, will showcase the company's growing
portfolio of advanced connected care solutions designed to foster
effective and efficient care for chronic respiratory and sleep
conditions. During the show, Philips will also unveil its newest
connected solution, Trilogy Evo, the only portable life support
ventilator platform designed to stay with patients to provide
consistent therapy and monitoring as they change care environments
and when their condition changes.

(Photo:
https://mma.prnewswire.com/media/743865/Philips_Trilogy.jpg )

(Photo:
https://mma.prnewswire.com/media/743866/Philips_Trilogy_Evo.jpg )

Chronic conditions such as Chronic Obstructive Pulmonary Disease
(COPD) can be difficult to manage due to complex care plans, large
care teams, and frequent readmissions.[1] Integrated with Care
Orchestrator (http://www.usa.philips.com/healthcare/product/HC1126366
/care-orchestrator?origin=20_us_en_careorchestrator_pr) , Philips'
sleep and respiratory care cloud-based management system, Trilogy Evo
will help to ease this burden by allowing physicians, clinicians, and
care providers to collaborate and coordinate care from hospital to
home by storing their patient prescription and therapy information in
a single secure location.

"Worldwide, chronic conditions are on the rise, presenting
continually growing care challenges. Time and again, we have seen the
positive impact that connected care can have not only on patients,
but on the care teams that serve them," said John Frank, Business
Leader for Sleep and Respiratory Care at Philips. "With effective
treatment options, chronic respiratory conditions can be managed
effectively. Trilogy Evo is our next evolution of work in connected
care solutions, making therapy management for chronic conditions
easier and more efficient."

Along with Trilogy Evo, Philips will showcase the latest suite of
integrated innovations in sleep and respiratory care including:

- Care Orchestrator (http://www.usa.philips.com/healthcare/product/HC
1126366/care-orchestrator?origin=20_us_en_careorchestrator_pr),
Philips cloud-based patient management software solution that
allows providers and clinicians to efficiently manage patient care
across a single platform. Through its cloud-based solutions like
Care Orchestrator, Philips enables the care of more than 8.5
million connected sleep and respiratory patients worldwide.
- NightBalance Lunoa is the latest treatment for positional sleep
apnea. The small, lightweight device worn in a belt around the
chest uses gentle vibrations to help stop wearers from sleeping on
their back. Over 73% of adults using the NightBalance Lunoa therapy
reported a long-term improvement in the three most reported
positional sleep apnea symptoms. [2]
- SmartSleep (http://www.usa.philips.com/c-e/smartsleep.html?origin=2
0_global_en_smartsleep_pr), the world's first and only clinically
proven wearable solution for consumers to improve deep sleep
quality for people who do not get enough sleep due to lifestyle.
After two weeks of use, 70 percent of users in a clinical trial
reported feeling less tired during the day. [3] Connectivity with
the Smart Sleep mobile application offers users with direct access
to sleep data and analysis.
- Philips DreamWear line (https://www.usa.philips.com/healthcare/prod
uct/HCNOCTN452/dreamwear?origin=10_us_en_dreamwearpr_pr), including
DreamWear Full Face (https://www.usa.philips.com/healthcare/product
/HC1133430/dreamwear-full-face-cushion-underthenose-full-face-cushi
on?origin=10_us_en_dwff_pr_pr), the newest option available for its
award-winning sleep mask line that places the hose on top of the
head instead of in front of the face, offering freedom of movement
and the ability to sleep in any position. Users and technicians can
easily swap cushions between DreamWear mask frames. CPAP users
reported being more satisfied with fit and comfort of the DreamWear
Full face mask over other leading full face masks. [4]
- DreamStation Go (http://www.sleepapnea.com/dreamstationgo?origin=10
_global_en_dsglaunchpr_pressrelease), At half the size of our
System One and DreamStation platforms, DreamStation Go offers the
same therapy and comfort features used by over 5 million CPAP users
and 1/3 components to pack than its closest competitors.
- DreamMapper (https://www.usa.philips.com/healthcare/product/HCNOCTN
196/dreammapper?origin=10_us_en_dreammapperpr_pr), the #1
downloaded and top-rated PAP therapy engagement mobile and
web-based application shown to enhance adherence. [5] 58 percent
more people use their therapy every night when using DreamMapper.
[6]

Additionally, Philips executives and partners will participate in
the following industry workshops during ERS 2018, sharing their
clinical insight into chronic sleep and respiratory conditions:

- Industry Practical Workshop: Sunday, September 16, 13:15 - 14:30,
Hall 7.3 I L - "Advance monitoring for a next generation
ventilator" hosted by
Teofilo Lee-Chiong, MD; Chief Medical Liaison at Philips with
speaker Cesare Gregoretti, MD.
- Industry Practical Workshop: Monday, September 17, 13:15 - 14:30,
Hall 7.3 I L - "Expiratory Flow Limitation - What it is and Why it
matters"
featuring Dr. Peter Calverley

To experience the entire portfolio of sleep and respiratory
products, visit Philips at ERS booth B06. For updates on Philips'
presence at ERS 2018, or more information on Philips' advanced
solutions for sleep and respiratory care, follow @PhilipsResp (https:
//twitter.com/PhilipsResp?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctw
gr%5Eauthor) or visit Philips.com/At-ERS-Congress.

[1] Global Initiative for Chronic Obstructive Lung Disease. 2017.
Retrieved from: http://goldcopd.org/gold-2017-global-strategy-diagnos
is-management-prevention-copd

[2] Dutch Apnea Society survey (Apneuvereniging) based on 75
NightBalance users for an average of 2.2 years.

Page 7, most reported symptoms, page 8, reported results by
symptom, mean results of top 3 symptoms.

[3] Home user trial 1 shows that 70% of chronically sleep deprived
participants rated their level of daytime sleepiness lower after 2
weeks than they did at baseline.

[4] Aug 2017 Patient Preference trial, n = 85; compared masks
included Resmed Airfit F10 and F20, Respironics Amara View and F&P
Simplus.

[5] Source: April 2018 review of Apple App Store®, Google Play(TM)
store and App Annie(TM).

[6] 19% of DreamMapper users used their therapy 100% of the nights
over 90-days versus 12% for the Standard Care users, a 58.33%
increase. In a retrospective review conducted by Philips Respironics
of the EncoreAnywhere database that compared DreamMapper patients
(n=85,077) to users who did not use it (n=87,602).

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health
technology company focused on improving people's health and enabling
better outcomes across the health continuum from healthy living and
prevention, to diagnosis, treatment and home care. Philips leverages
advanced technology and deep clinical and consumer insights to
deliver integrated solutions. Headquartered in the Netherlands, the
company is a leader in diagnostic imaging, image-guided therapy,
patient monitoring and health informatics, as well as in consumer
health and home care. Philips generated 2017 sales of EUR 17.8
billion and employs approximately 75,000 employees with sales and
services in more than 100 countries. News about Philips can be found
at http://www.philips.com/newscenter.

ots Originaltext: Royal Philips
Im Internet recherchierbar: http://www.presseportal.de

Contact:
Kathy O'Reilly
Philips Group Press Office
Mobile: +1-978-221-8919
E-mail: kathy.oreilly@philips.com

Meredith Amoroso
Philips Sleep and Respiratory Care
Mobile: +1-724-584-8991
E-mail: meredith.amoroso@philips.com

Original-Content von: Royal Philips, übermittelt durch news aktuell